Monogram Orthopaedics (MGRM) vs. Its Peers Head-To-Head Comparison

Monogram Orthopaedics (NASDAQ:MGRM) is one of 221 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Monogram Orthopaedics to related businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Monogram Orthopaedics and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Monogram Orthopaedics	0	0	0	0	N/A
Monogram Orthopaedics Competitors	1538	4128	8135	192	2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 22.81%. Given Monogram Orthopaedics’ competitors higher possible upside, analysts plainly believe Monogram Orthopaedics has less favorable growth aspects than its competitors.

Profitability

This table compares Monogram Orthopaedics and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Monogram Orthopaedics	N/A	-143.70%	-83.17%
Monogram Orthopaedics Competitors	-673.74%	-325.44%	-30.33%

Insider and Institutional Ownership

0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 47.9% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 15.1% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Monogram Orthopaedics and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Monogram Orthopaedics	$370,000.00	-$13.74 million	-2.92
Monogram Orthopaedics Competitors	$1.10 billion	$4.12 million	-10.03

Monogram Orthopaedics’ competitors have higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Monogram Orthopaedics competitors beat Monogram Orthopaedics on 5 of the 9 factors compared.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.